# Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy

> **NCT04043325** · — · UNKNOWN · sponsor: **University Children's Hospital, Zurich** · enrollment: 100 (estimated)

## Conditions studied

- Community-acquired Pneumonia

## Interventions

- **DIAGNOSTIC_TEST:** Specific antibody-secreting cell (ASC) enzyme-linked immunspot (ELISpot) assay

## Key facts

- **NCT ID:** NCT04043325
- **Lead sponsor:** University Children's Hospital, Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-20
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04043325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04043325, "Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04043325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*